3K3A-APC: Phase I started

Socratech's ZZ Biotech LLC company began a double-blind, placebo-controlled, Austrian Phase I trial to evaluate single and multiple ascending-doses of up to 720 µg/kg IV 3K3A-APC in about 62 healthy ...